Issue 29
Get instant access to latest e-book

latest newsRead more...

16

Feb 2018

Roche to acquire Flatiron Health

Roche and Flatiron Health Inc announced today that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health following on from an existing equity stake of The transaction is expected to close in the first half of…

16

Feb 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT

Arrowhead Pharmaceuticals Inc announced the United States Food and Drug Administration FDA has granted orphan drug designation to AROAAT Arrowheads secondgeneration investigational medicine for the treatment of a rare genetic liver disease associated with alpha antitrypsin deficiency Arrowhead filed a Clinical Trial Application in December…

15

Feb 2018

Bristol-Myers Squibb and Nektar Therapeutics Announce Global Development & Commercialization Collaboration

BristolMyers Squibb Company and Nektar Therapeutics announced the companies have executed a global strategic development and commercialization collaboration for Nektars lead immunooncology program NKTR Under the collaboration the companies will jointly develop and commercialize NKTR in combination with BristolMyers Squibbs Opdivo nivolumab and Opdivo plus…

press releasesRead more...

17

Feb 2018

Cardax\'s ZanthoSyn® is No. 1 Seller at GNC Hawaii Stores

HONOLULU Feb PRNewswire Cardax Inc OTCQB CDXI announced today that ZanthoSyn count the Companys premium astaxanthin dietary supplement for inflammatory health and longevity was the top selling product in Hawaii…

17

Feb 2018

Cardax Inks Deal to Distribute ZanthoSyn® in China

HONOLULU Feb PRNewswire Cardax Inc OTCQB CDXI announced today that it has signed a Purchase Agreement the Agreement with Health Elite Club Limited HECL of Hong Kong for distribution of…

17

Feb 2018

AbbVie Presents New Late-Breaking Phase 2b Data on Upadacitinib in Atopic Dermatitis at the 2018 American Academy of Dermatology Annual Meeting

NORTH CHICAGO Ill Feb PRNewswire AbbVie NYSE ABBV a global research and developmentbased biopharmaceutical company today presented new positive results from a Phase b doseranging study evaluating upadacitinib an investigational…

EventsRead more...

22-24

Feb 2018

Global Logistics Show

Infinityexpo
Bombay Exhibition Centre, Mumbai

23-25

Feb 2018

Arab League Against Rheumatism - ArLAR 2018

K.I.T Group Middle East FZ L.L.C
Grand Millennium Hotel

TOP ARTICLES

  • 1

    Mesoporous Silica Nanoparticles

    Mesoporous Silica Nanoparticles MSNs have attracted great attention over the last decade as a drug delivery system in the fields of biotechnology and Nano medic..
  • 6

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Blood-Brain Barrier and CNS Drug Delivery

    Introduction The idea of Blood Brain Barrier BBB dates back to more than years ago when Paul Erlich observed that by intravenous injection of certain dyes all organs of the animal body were stained except the brain and the spinal cord The densely packed brain endothelial cells are the main part of BBB which…

  • Techno Trends

    First Digital Pill Tracks Patients Medication

    Abilify MyCite the first digital pill with a sensor digitally tracks if patients have taken their medication Abilify MyCite also gets an approval from the US Food and Drug Administration FDA This first digital pill is fitted with a digital ingestion tracking system and has an ingestible sensor embedded in the pill that records that the medication was taken The…

Editorial Section

  • Strategy

    Globalisation

    As the pharmaceutical industry squares off against the challenge of globalisation there is a greater need for content than ever Driven by forces from both the clinical and commercial sides pharmaceutical companies are experiencing rising costs and competition Ultimately to…

  • Research development

    Knowing vs Hunting for Targets

    Selecting a target for settingup the drug discovery path is a tough decision and often this choice is based on borrowed and incomplete knowledge from the literature In many cases this has led to serious challenges in the late stages…

  • Clinical Trials

    Use of Real World Evidence

    Real World Evidence RWE can be used to inform decisions throughout the life cycle of a drug from development through postapproval Across Asia many countries have begun incorporating real world evidence and while some are fast adopters in terms of…

  • Manufacturing

    Cultural Excellence as the Foundation

    In pharmaceutical companies it is universally understood that a robust Pharmaceutical Quality System PQS provides key elements of assurance and oversight for pharmaceutical manufacturing and quality control laboratory processes However despite recent advances in the…

  • Expert Talk

    Pushing the Limits of Temperature Control

    Todays pharmaceutical environment has become increasingly complex with more specialty products like biologics injectable and clinical trial drugs being shipped than ever The industry standard for commercial packaging is hours which is no longer always…

TOP